139 results
8-K
EX-10.1
SNGX
Soligenix Inc
22 Apr 24
Soligenix Announces Pricing of $4.75 Million Public Offering
4:05pm
basis only and that the execution of this Agreement does not constitute a commitment by the Placement Agent to purchase the Placement Agent Securities
8-K
tr5p uagmcy6k
3 May 23
Strengthens regulatory and orphan drug development expertise
5:00pm
8-K
EX-99.1
4qty00v8 0y7
3 May 23
Strengthens regulatory and orphan drug development expertise
5:00pm
424B5
ts8kr3 zswqkgq1
13 Aug 21
Prospectus supplement for primary offering
4:11pm
8-K
EX-10.1
j12sgkegw6cbcdy79k
16 Dec 20
Soligenix Announces $20 Million Strategic Convertible Debt Financing Agreement with Pontifax Medison Debt Financing
4:31pm
8-K
EX-4.1
ywd5muunbrn
16 Dec 20
Soligenix Announces $20 Million Strategic Convertible Debt Financing Agreement with Pontifax Medison Debt Financing
4:31pm
424B5
31wubtwztrg jkwl3yv
28 Aug 20
Prospectus supplement for primary offering
4:48pm
424B5
8vme2opgj7g3zro6j9
10 Apr 20
Prospectus supplement for primary offering
4:16pm
424B5
olouig8u
20 Mar 20
Prospectus supplement for primary offering
4:06pm